Into the Weeds of Refractive Screening

Experts share how they decide whether or not a cornea-based procedure is appropriate for a potential candidate.

April 2024

Read Digital Edition

Read PDF Edition

Subscriptions

Featured Content

IOLs

The Journey to True Accommodation

Various companies have been working for years to develop intraocular lenses that achieve true accommodation.

Glaucoma

First-Line Treatment: SLT or Medication?

Medication has historically been the gold standard, but recent success with SLT is giving surgeons more options.

Cataract Surgery

Maximizing Vision After Cataract Surgery

Most surgeries are successful, but there are some patients who aren’t happy with their vision for no obvious reason, and surgeons have to delve deeper.

Practice Management

How Practices Are Making Private Equity Work

Any partnership can have its ups and downs, but so far, ophthalmologists seem to say it’s working out.

Meetings

Monday, May 6, 2024 | Eylea HD for Wet AMD, DME, and DR

Review of Ophthalmology Online eNewsletter

In this Issue:

Frequency of VF Testing of POAG Patients
Did most subjects receive at least one visual field test per year?
Reticular Pseudodrusen: Macular Risk Feature for Late AMD Progression

See the nuances of this new biomarker.
Refractive Stability, Axial Elongation & Related Factors in a High Myopia Population After ICL Implantation
Learn the status of myopic progression and axial elongation after surgery.
Baseline Sattler Layer Choriocapillaris Complex Thickness Cutoffs & AMD Progression
Discover whether choroidal impairment contributes to disease progression.
Industry News

Continuing Medical Education

Seeing Eye to Eye on the Management of Neurotrophic Keratitis

This educational activity features real-world cases of patients with various stages of NK and aims to provide ophthalmologists with clinical data and pearls to aid in the diagnosis and treatment of NK.
Expressions on Evaporation: Clinical Perspectives on the Management of Dry Eye Disease
Corneal nerves have an essential role in maintaining ocular surface health and homeostasis. Manifestations of neurosensory abnormalities affecting corneal innervation include dry eye disease, neurotrophic keratopathy, and neuropathic corneal pain. These conditions can exist as a standalone entity, but they can also be concurrent and have overlapping features, making diagnosis challenging. Early diagnosis of dry eye disease, neurotrophic keratopathy, and neuropathic corneal pain is important to allow intervention that can help to restore function and improve quality of life. This educational activity reviews common diagnostic modalities that can be used by clinicians to identify these conditions.

Credit: Physicians: 1.00 AMA PRA Category 1 Credit™
Global Perspectives on Steroids: Study Designs and Diabetic Macular Edema Management Around the World (Text-based)

Earn free CME credits learning about the 1) Clinical Relevance of Protocol U 2) Real-life Experience with Dexamethasone Intravitreal Implants in Patients with DME 3) the Rationale for Early-Switch and First-Line Dexamethasone Implants for DME Management 4) Real World Use of Dexamethasone for DME and 5) the Fluocinolone Acetonide Intravitreal Implant for DME

Credit: Physicians: 0.50 AMA PRA Category 1 Credit(s)™
Problem-Based Learning: Diagnosing and Managing Neurotrophic Keratitis

Join clinical experts as they discuss a problem-based learning approach to enhance cognition of best practices for diagnosing and managing neurotrophic keratitis (NK).
Credit: Physicians: 0.50 AMA PRA Category 1 Credit(s)™
Optimal Diagnosis and Treatment of Blepharoptosis

In this CME Monograph from MedEdicus, a panel of expert ophthalmologists will review the common causes of ptosis and traditional therapies for ptosis correction. The panel will also review the clinical data for oxymetazoline 0.1%, a new topical medical therapy approved for ptosis treatment. In addition, a series of cases will be discussed to demonstrate the systematic evaluation of patients with ptosis and the development of individualized treatment plans.